Letter by Zhang and Xu Regarding Article, “Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
We read with great interest the article presented by Rowin and colleagues1 about the clinical course and management of atrial fibrillation (AF) in hypertrophic cardiomyopathy (HCM). This large cohort study provided new information and favorable results on AF and its impact on …